According to this article in outsourcing-pharma.com CROS and drug companies that are conducting clinical trials in India will now be required to record full details of all their research including the funding source.
Up until now, registration on Indian Council of Medical Research (ICMR) website was done voluntarily, but now that will all change come this June. Last summer 49 infants died in clinical trials in India, and an infant that died in October should have never been part of the trial because the baby had existing heart problems. As a result of this, the committee wants to be able to regulate and monitor all patients before they are enrolled.
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
April
(30)
- Inspirational Patient Perspective with NFL Legend ...
- Welcome to The Second and Final Day of the Conference
- Virtual Pharma: Addressing Challenges and Opportun...
- Understanding the Concepts of Disruptive Innovatio...
- Creating a Competitive Advantage through Sourcing
- Approaches to Address the Impact of Increasingly C...
- Clinical Trials: What Does Global Mean to You?
- MMAX: Development, Evolution, Growth and Maturatio...
- Leading Through Change: Innovation and the Future ...
- Wall Street’s 2009 Forecast and Analysis of Outsou...
- Live from the 18th Annual Partnerships with CROs
- Driving Global Growth: Strategic Considerations f...
- Governance and Supplier Relationship Management
- FierceBiotech is the Official Digital Media and Li...
- Speaker Profile: Peter B. Corr
- Speaker Profile: Harris Koffer, Pharm.D
- Speaker Profile: Christopher C. Gallen, MD, PhD
- Clinical trial begins for a malaria vaccine
- The Use of Bid Grids for Selecting a CRO as a Partner
- Partnerships with CROs April LinkedIn Update: Merg...
- Full Details are Required for Indian Clinical Trials
- Join us: Global Congress on Comparator Studies
- Partnerships with CROs & Other Outsourcing Provide...
- Patient recruitment costs continue to increase in ...
- Key Findings on CRO Industry
- France focuses on Clinical Trials
- CardioNet Expands into CRO Industry by Acquring Bi...
- The Political Economy of Pharmaceutical Clinical T...
- ICON teaming up with MedAvante
- New CenterWatch Report Examines Japan’s Surging Cl...
-
▼
April
(30)
No comments:
Post a Comment